Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

PepHaūs vs Voxy

By GLP-1 ScorecardUpdated

PepHaūsFactor scores not reassessed.
Site position #25

Higher score

VoxyFactor scores not reassessed.
Site position #295

Lower score

Score comparison

PepHaūs has the higher recorded score — 82.7/100 to 62.4/100.

PepHaūs grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Compare monthly billing with prepaid commitments, then confirm renewal pricing and supply.

Before you choose

Before comparing the headline prices, the PepHaūs review and the Voxy review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, PepHaūs vs VyrarX and Piper vs Voxy compare each of them with another graded program, and the list of alternatives to PepHaūs ranks the programs closest to PepHaūs on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the GoodLife Health review covers one graded close to these two, at 69.8/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valuePepHaūs +31
82
51
Dose & formulationPepHaūs +16
80
64
Clinical oversightPepHaūs +2
84
82
Labs & monitoringPepHaūs +19
82
63
FulfillmentPepHaūs +8
86
78
Contract termsPepHaūs +65
85
20
PepHaūs · top barVoxy · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricPepHaūsVoxy
WeighScore82.7/10062.4/100
GradeB−C
Site position#25#295
Semaglutide$169 monthly; prepaid plans available (advertised)$175/mo month-to-month ($99/mo on 12-month plan billed annually; compounded)
Tirzepatide$239 monthly; prepaid plans available (advertised)$225/mo month-to-month ($135/mo on 12-month plan billed annually; compounded)
CoverageClaims all 50 states plus DC; treatment eligibility requires confirmationCoverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
PepHaūs

Site position #25 · B−

Factor scores not reassessed.

Strengths

  • Publishes monthly and prepaid plan amounts
  • Names provider and pharmacy partners

What to consider

  • Price-lock wording needs reconciling with renewal terms
  • Actual supply and longer-plan shipments remain unverified
  • Independent license and certification status remain unverified
Voxy

Site position #295 · C

Factor scores not reassessed.

Strengths

  • Names both its compounding pharmacy (VialsRX, Houston TX) and its prescribing medical group (Arora Health & Aesthetics) — most name neither
  • Publishes the full price ladder for both drugs across 1-, 3-, 6- and 12-month terms before you start the assessment
  • One price covers the provider visit, medication, injection supplies, shipping and monthly check-ins — no separate membership fee
  • True month-to-month option at $175 semaglutide / $225 tirzepatide with no commitment required
  • Free assessment with no charge to see if you qualify, and no labs required to start

What to consider

  • No terms of service anywhere on the site — /terms, /terms-of-service and /terms-of-use all return 404
  • No refund policy published; the only stated commitment language is 'cancel anytime'
  • The lowest advertised rates ($99 semaglutide, $135 tirzepatide) require a 12-month plan billed annually; month-to-month is $175 and $225
  • No public list of states served; availability depends on where affiliated providers are licensed
  • The prescribing nurse practitioner is not named — 'provider details available during your consultation'

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard